About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
8th Annual Houston Methodist Cancer Symposium
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
2020 Update on Myelofibrosis: Beyond Ruxolitinib - How Effective Are Fedratinib, Pacritinib, and Navitoclax?
By
8th Annual Houston Methodist Cancer Symposium
FEATURING
Prithviraj Bose
By
8th Annual Houston Methodist Cancer Symposium
FEATURING
Prithviraj Bose
190 views
September 9, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Videos
12:58
8th Annual Houston Methodist Cancer Symposium
Current Concepts in Mastocytosis: Diagnostic Algorithms, Pathology T…
Feat.
T. George
21:59
8th Annual Houston Methodist Cancer Symposium
New Developments in Mastocytosis Therapy: Updates on Avapritinib Cli…
Feat.
T. George
25:22
8th Annual Houston Methodist Cancer Symposium
ctDNA Based NGS Testing in NSCLC: What Are the Clinical Implications…
Feat.
C. Aggarwal
18:54
8th Annual Houston Methodist Cancer Symposium
The Importance of Molecular Testing in NSCLC: Which Biomarkers Shoul…
Feat.
C. Aggarwal
32:59
8th Annual Houston Methodist Cancer Symposium
2020 Update on Cancer Advocacy: How Can Patient Advocates Help Cance…
Feat.
J. Feldman
34:35
8th Annual Houston Methodist Cancer Symposium
Oncolytic Viruses & IO in Lung Cancers: Can the Use of Oncolytic…
Feat.
E. Bernicker
41:41
8th Annual Houston Methodist Cancer Symposium
2020 Update on Small Biopsies in Lung Cancer: How to Process, Select…
Feat.
S. Roy-Chowdhuri
30:55
8th Annual Houston Methodist Cancer Symposium
2020 Update on Myelofibrosis: Beyond Ruxolitinib - How Effective Are…
Feat.
P. Bose
33:03
8th Annual Houston Methodist Cancer Symposium
2020 Update on Allogeneic HCT in Myelofibrosis: What Is the Role of …
Feat.
L. Hill
31:38
8th Annual Houston Methodist Cancer Symposium
2020 Update on MPN: What Do Diagnosis & Genetic Prognostication …
Feat.
A. Tefferi
17:24
8th Annual Houston Methodist Cancer Symposium
2020 Update on MPN: What Are the Current Treatment Algorithms for ET…
Feat.
A. Tefferi
